SOURCE: Prolacta Bioscience

Prolacta Bioscience

July 26, 2016 16:46 ET

Prolacta Bioscience Receives Social Impact Award From Association for Corporate Growth

CITY OF INDUSTRY, CA--(Marketwired - Jul 26, 2016) - Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the Association for Corporate Growth Los Angeles (ACG LA) honored the company with a Social Impact Award during the ACG LA's 6th Annual Awards Ceremony at the Walt Disney Concert Hall. Each year, ACG LA, which is one of the largest and most-active chapters of ACG, honors exceptional companies in Los Angeles who demonstrate outstanding performance and leadership.

"It's an honor to present our Social Impact Award to Prolacta Bioscience for the impact they've had on our community," said Steve Moon, president of the Association for Corporate Growth Los Angeles. "Prolacta has a strong and growing presence in LA and has shown a dedication to social impact and leadership in their industry, which makes them uniquely suited for this award." 

"It's a privilege to be recognized by the Association for Corporate Growth Los Angeles and our fellow LA-area businesses for the work that we're doing to change the standard of care in neonatal intensive care units worldwide by Advancing the Science of Human Milk," said Scott Elster, president and CEO of Prolacta Bioscience. "We are grateful for the award from the Association and look forward to many years working in collaboration to support corporate growth in Los Angeles."

About Prolacta Bioscience
Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based Neonatal Nutritional Products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from donor breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk. For more information please visit www.prolacta.com.

Contact Information